Insider Selling: USANA Health Sciences (NYSE:USNA) CFO Sells 5,360 Shares of Stock

USANA Health Sciences, Inc. (NYSE:USNA) CFO G Doug Iiekking sold 5,360 shares of the company’s stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $18.75, for a total value of $100,500.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

USANA Health Sciences Price Performance

USANA Health Sciences stock traded up $0.01 during trading hours on Thursday, hitting $18.81. The stock had a trading volume of 17,321 shares, compared to its average volume of 125,246. The stock has a market capitalization of $347.23 million, a price-to-earnings ratio of 40.02, a PEG ratio of 0.72 and a beta of 0.77. USANA Health Sciences, Inc. has a 1-year low of $16.60 and a 1-year high of $38.32. The stock’s fifty day moving average is $18.26 and its two-hundred day moving average is $19.47.

USANA Health Sciences (NYSE:USNA) last posted its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.44 by $0.17. The company had revenue of $250.22 million for the quarter, compared to analyst estimates of $240.99 million. USANA Health Sciences had a return on equity of 6.21% and a net margin of 0.96%.USANA Health Sciences has set its FY 2026 guidance at 1.950-2.290 EPS. As a group, sell-side analysts anticipate that USANA Health Sciences, Inc. will post 2.12 EPS for the current year.

Institutional Trading of USANA Health Sciences

Several institutional investors and hedge funds have recently made changes to their positions in the stock. UBS Group AG lifted its position in USANA Health Sciences by 252.3% during the fourth quarter. UBS Group AG now owns 138,334 shares of the company’s stock worth $2,715,000 after buying an additional 99,063 shares during the period. Allianz Asset Management GmbH lifted its position in USANA Health Sciences by 126.0% during the third quarter. Allianz Asset Management GmbH now owns 47,203 shares of the company’s stock worth $1,300,000 after buying an additional 26,314 shares during the period. Exchange Traded Concepts LLC lifted its position in USANA Health Sciences by 11.0% during the fourth quarter. Exchange Traded Concepts LLC now owns 52,411 shares of the company’s stock worth $1,029,000 after buying an additional 5,207 shares during the period. Tudor Investment Corp ET AL purchased a new position in USANA Health Sciences during the third quarter worth about $664,000. Finally, Dynamic Technology Lab Private Ltd purchased a new position in USANA Health Sciences during the third quarter worth about $266,000. 54.25% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

USNA has been the topic of several research reports. Zacks Research lowered USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 22nd. Weiss Ratings restated a “sell (d)” rating on shares of USANA Health Sciences in a research report on Friday, March 27th. Finally, Wall Street Zen downgraded USANA Health Sciences from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, USANA Health Sciences presently has a consensus rating of “Reduce”.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc is a Utah‐based company that develops, manufactures and distributes nutritional supplements and personal care products through a network of independent distributors. Founded in 1992 by Dr. Myron Wentz, the company’s portfolio includes vitamins, minerals, dietary supplements, weight‐management products and skin‐care formulations. USANA’s products are formulated in its own laboratories to meet pharmaceutical‐grade standards, and the company has invested heavily in research and development and quality control to support its offerings.

Operating primarily through a direct selling model, USANA serves markets in North America, Asia Pacific, Europe and Latin America.